Mary Lynne Hedley Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mary Lynne Hedley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mary Lynne Hedley. Mary Lynne Hedley is Exec VP & Chief Scientific Off in MGI PHARMA INC ($MOGN) and Sr. VP & Chief Scientific Off in MGI PHARMA INC ($MOGN) and Director in bluebird bio, Inc. ($BLUE) and Director in VEEVA SYSTEMS INC ($VEEV) and Director in Receptos, Inc. ($RCPT) and PRESIDENT & COO in TESARO, Inc. ($TSRO) and President and COO in TESARO, Inc. ($TSRO) and Director in Millendo Therapeutics, Inc. ($OVAS).
Latest Insider Trading Transactions of Mary Lynne Hedley
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BLUE, MOGN, OVAS, RCPT, TSRO, VEEV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26 2021 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 12 | 0 | 11 | |
| Mar 26 2021 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 211 | 0 | 211 | |
| Mar 26 2021 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 12 | 0 | 1,709 | 1.7 K to 1.7 K (+0.71 %) |
| Mar 26 2021 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 211 | 0 | 1,697 | 1.5 K to 1.7 K (+14.20 %) |
| Jan 13 2021 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Sell | S | 288.54 | 95 | 27,411 | 1,486 | 1.6 K to 1.5 K (-6.01 %) |
| Dec 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 11 | 0 | 23 | |
| Dec 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 212 | 0 | 422 | |
| Dec 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 11 | 0 | 1,581 | 1.6 K to 1.6 K (+0.70 %) |
| Dec 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 212 | 0 | 1,570 | 1.4 K to 1.6 K (+15.61 %) |
| Sep 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 11 | 0 | 34 | |
| Sep 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 11 | 0 | 34 | |
| Sep 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 211 | 0 | 634 | |
| Sep 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 211 | 0 | 634 | |
| Sep 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 11 | 0 | 1,358 | 1.3 K to 1.4 K (+0.82 %) |
| Sep 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 11 | 0 | 1,358 | 1.3 K to 1.4 K (+0.82 %) |
| Sep 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 211 | 0 | 1,347 | 1.1 K to 1.3 K (+18.57 %) |
| Sep 28 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 211 | 0 | 1,347 | 1.1 K to 1.3 K (+18.57 %) |
| Jul 24 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | A | 0.00 | 45 | 0 | 45 | |
| Jun 26 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | A | 0.00 | 845 | 0 | 845 | |
| Jun 23 2020 | OVAS | Millendo Therapeut ... | Hedley Mary Lynne | Director | Option Exercise | A | 2.40 | 12,000 | 28,800 | 12,000 | |
| Jun 18 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 114 | 0 | 0 | |
| Jun 18 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 114 | 0 | 1,136 | 1 K to 1.1 K (+11.15 %) |
| May 19 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 341 | 0 | 114 | |
| May 19 2020 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 341 | 0 | 1,022 | 681 to 1 K (+50.07 %) |
| Dec 16 2019 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | M | 0.00 | 340 | 0 | 796 | |
| Dec 16 2019 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Buy | M | 0.00 | 340 | 0 | 340 | 0 to 340 |
| Sep 19 2019 | VEEV | VEEVA SYSTEMS INC | Hedley Mary Lynne | Director | Option Exercise | A | 0.00 | 1,136 | 0 | 1,136 | |
| Jun 21 2019 | OVAS | Millendo Therapeut ... | Hedley Mary Lynne | Director | Option Exercise | A | 11.59 | 12,000 | 139,080 | 12,000 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 55.84 | 71,896 | 4,014,673 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 178.95 | 20,216 | 3,617,653 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 43.39 | 80,000 | 3,471,200 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 55.11 | 115,000 | 6,337,650 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 33.74 | 105,000 | 3,542,700 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 24.18 | 175,000 | 4,231,500 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 6.62 | 319,467 | 2,113,274 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 1.33 | 285,714 | 380,000 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 0.00 | 40,909 | 0 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 0.00 | 8,339 | 0 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Sell | U | 75.00 | 563,569 | 42,267,675 | 0 | 563.6 K to 0 (-100.00 %) |
| Jan 22 2019 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Sell | U | 75.00 | 26,816 | 2,011,200 | 0 | 26.8 K to 0 (-100.00 %) |
| Jan 17 2019 | OVAS | Millendo Therapeut ... | Hedley Mary Lynne | Director | Option Exercise | A | 8.80 | 6,000 | 52,800 | 6,000 | |
| Jan 17 2019 | OVAS | Millendo Therapeut ... | Hedley Mary Lynne | Director | Option Exercise | A | 8.80 | 6,000 | 52,800 | 6,000 | |
| Dec 21 2018 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | M | 6.62 | 23,390 | 154,725 | 296,101 | |
| Dec 21 2018 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Payment of Exercise | F | 73.10 | 11,572 | 845,913 | 26,816 | 38.4 K to 26.8 K (-30.14 %) |
| Dec 21 2018 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Buy | M | 6.62 | 23,390 | 154,725 | 38,388 | 15 K to 38.4 K (+155.95 %) |
| Dec 11 2018 | OVAS | Millendo Therapeut ... | Hedley Mary Lynne | Director | Option Exercise | A | 16.40 | 18,600 | 305,040 | 18,600 | |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Hedley Mary Lynne | Director | Option Exercise | A | 183.10 | 4,000 | 732,400 | 4,000 | |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Hedley Mary Lynne | Director | Grant | A | 0.00 | 1,000 | 0 | 3,700 | 2.7 K to 3.7 K (+37.04 %) |
| Mar 05 2018 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | A | 55.84 | 71,896 | 4,014,673 | 71,896 | |
| Mar 05 2018 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | A | 0.00 | 40,909 | 0 | 40,909 | |
| Mar 05 2018 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | M | 0.00 | 2,780 | 0 | 8,339 | |
| Mar 05 2018 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Option Exercise | M | 0.00 | 10,000 | 0 | 20,000 | |
| Mar 05 2018 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Sell | S | 54.86 | 3,855 | 211,485 | 14,998 | 18.9 K to 15 K (-20.45 %) |
| Mar 05 2018 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Buy | M | 0.00 | 2,780 | 0 | 18,853 | 16.1 K to 18.9 K (+17.30 %) |
| Mar 05 2018 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President & COO | Buy | M | 0.00 | 10,000 | 0 | 16,073 | 6.1 K to 16.1 K (+164.66 %) |
| Sep 20 2017 | BLUE | bluebird bio, Inc. | Hedley Mary Lynne | Director | Option Exercise | A | 133.05 | 10,700 | 1,423,635 | 10,700 | |
| Sep 20 2017 | BLUE | bluebird bio, Inc. | Hedley Mary Lynne | Director | Grant | A | 0.00 | 2,700 | 0 | 2,700 | 0 to 2.7 K |
| Mar 03 2016 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President and COO | Option Exercise | A | 43.39 | 80,000 | 3,471,200 | 80,000 | |
| Mar 03 2016 | TSRO | TESARO, Inc. | Hedley Mary Lynne | President and COO | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
| Aug 27 2015 | RCPT | Receptos, Inc. | Hedley Mary Lynne | Director | Option Exercise | D | 27.44 | 1,390 | 38,142 | 0 | |
| Aug 27 2015 | RCPT | Receptos, Inc. | Hedley Mary Lynne | Director | Option Exercise | D | 37.73 | 18,800 | 709,324 | 0 | |
| Aug 27 2015 | RCPT | Receptos, Inc. | Hedley Mary Lynne | Director | Sell | D | 0.00 | 7,400 | 0 | 0 | 7.4 K to 0 (-100.00 %) |
| Jun 01 2015 | RCPT | Receptos, Inc. | Hedley Mary Lynne | Director | Grant | A | 0.00 | 7,400 | 0 | 7,400 | 0 to 7.4 K |
| Mar 10 2015 | TSRO | TESARO, Inc. | Hedley Mary Lynne | PRESIDENT & COO | Option Exercise | A | 55.11 | 115,000 | 6,337,650 | 0 | |
| Jan 30 2008 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Option Exercise | D | 29.28 | 52,500 | 1,537,200 | 0 | |
| Jan 30 2008 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Option Exercise | D | 28.06 | 5,000 | 140,300 | 0 | |
| Jan 30 2008 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Option Exercise | D | 26.91 | 17,500 | 470,925 | 0 | |
| Jan 30 2008 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Option Exercise | D | 15.13 | 75,000 | 1,134,750 | 0 | |
| Jan 30 2008 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Option Exercise | D | 22.87 | 50,000 | 1,143,500 | 0 | |
| Jan 30 2008 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Sell | D | 41.00 | 36,333 | 1,489,653 | 0 | 36.3 K to 0 (-100.00 %) |
| Jan 30 2008 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Grant | A | 0.00 | 18,083 | 0 | 36,333 | 18.3 K to 36.3 K (+99.08 %) |
| Jan 25 2008 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Sell | U | 41.00 | 1,835 | 75,235 | 0 | 1.8 K to 0 (-100.00 %) |
| Jan 25 2008 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Sell | U | 41.00 | 14,989 | 614,549 | 18,250 | 33.2 K to 18.3 K (-45.09 %) |
| Sep 05 2007 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Payment of Exercise | F | 23.57 | 1,587 | 37,406 | 33,239 | 34.8 K to 33.2 K (-4.56 %) |
| Jul 16 2007 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Payment of Exercise | F | 25.37 | 278 | 7,053 | 34,826 | 35.1 K to 34.8 K (-0.79 %) |
| Feb 22 2007 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Option Exercise | A | 22.87 | 50,000 | 1,143,500 | 50,000 | |
| Oct 04 2006 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Payment of Exercise | F | 17.21 | 238 | 4,096 | 23,604 | 23.8 K to 23.6 K (-1.00 %) |
| Sep 05 2006 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Payment of Exercise | F | 15.06 | 2,381 | 35,858 | 23,842 | 26.2 K to 23.8 K (-9.08 %) |
| Sep 01 2006 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Option Exercise | A | 15.13 | 75,000 | 1,134,750 | 75,000 | |
| Sep 01 2006 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Exec VP & Chief Sci ... | Grant | A | 0.00 | 20,000 | 0 | 26,223 | 6.2 K to 26.2 K (+321.39 %) |
| Jul 17 2006 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Sr. VP & Chief Scie ... | Payment of Exercise | F | 20.58 | 277 | 5,701 | 3,223 | 3.5 K to 3.2 K (-7.91 %) |
| Oct 06 2005 | MOGN | MGI PHARMA INC | Hedley Mary Lynne | Sr. VP & Chief Scie ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Page: 1